HER2-Low Breast Cancer: Molecular Characteristics and Prognosis.

Agostinetto, Elisa; Rediti, Mattia; Fimereli, Danai; Debien, Véronique; Piccart, Martine; Aftimos, Philippe; Sotiriou, Christos; de Azambuja, Evandro.

Afiliação

Agostinetto E; Academic Trials Promoting Team, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B), 1000 Brussels, Belgium.
Rediti M; Humanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, Via Manzoni 56, 20089 Milan, Italy.
Fimereli D; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Milan, Italy.
Debien V; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.
Piccart M; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.
Aftimos P; Academic Trials Promoting Team, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B), 1000 Brussels, Belgium.
Sotiriou C; Medical Oncology Department, Institut Jules Bordet, 1000 Brussels, Belgium.
de Azambuja E; Clinical Trials Conduct Unit, Institut Jules Bordet-Université Libre de Bruxelles, 1000 Brussels, Belgium.

Cancers (Basel) ; 13(11)2021 Jun 05.

Article em En | MEDLINE | ID: mdl-34198891